DSA (Donor Specific IgG Antibodies to Class I & II)

The DSA test detects antibodies in the recipient’s blood that are directed against the donor’s organ after transplantation. It is critical for evaluating transplant rejection and managing post-transplant care. The test helps identify patients at risk for graft rejection.

Also known asDsa (donor Specific Antibodies) Dsa (donor Specific Antibodies)

Available via

Home Collection, Lab Visit

Contains

5 parameters

Earliest reports in

2 Working Days

Test details

DSA (Donor Specific IgG Antibodies to Class I & II) Test in Bengaluru Overview

What is DSA, Donor Specific IgG Antibodies to Class I & II test?

What is DSA, Donor Specific IgG Antibodies to Class I & II test is a blood test that detects IgG antibodies in a transplant recipient directed specifically against the donor’s HLA Class I (A, B, C) and Class II (DR, DQ, DP) antigens, which are a major cause of antibody‑mediated graft injury and rejection.

Why consider DSA, Donor Specific IgG Antibodies to Class I & II test?

  • Presence of DSA is strongly associated with antibody‑mediated rejection (AMR), graft dysfunction, and inferior graft survival across solid organ transplants, making it critical for risk assessment and monitoring.
  • Complement‑binding or certain IgG subclasses (notably IgG1/IgG3) indicate higher pathogenic potential, helping refine risk stratification and management decisions.

Who should get this DSA, Donor Specific IgG Antibodies to Class I & II test?

  • Transplant candidates during pre‑transplant workup to detect preformed DSA and guide organ acceptance, desensitization, or allocation strategies.
  • Post‑transplant recipients for routine surveillance or when there is graft dysfunction, to detect de novo DSA and guide timely interventions.

More Information about DSA, Donor Specific IgG Antibodies to Class I & II test

Donor-specific IgG antibodies are anti-HLA antibodies produced by a transplant recipient that specifically recognize the donor’s HLA Class I (A, B, C) and/or Class II (DR, DQ, DP) antigens, and they are a key biomarker for antibody-mediated rejection and graft injury.

Preformed DSA present before transplant can provoke hyperacute or early acute rejection and influence organ acceptance decisions, particularly if they cause a positive T-cell crossmatch.

Other Names: HLA DSA (Donor‑Specific Antibody) Class I & II; Donor‑specific HLA antibody; DSA monitoring; HLA antibody specificity monitoring

Preparations

No special preparations needed

Test included
DSA (Donor Specific IgG Antibodies to Class I & II) includes 5 parameters

  • Dsa Class I - Mean Fluoroscence Intensity (mfi)
  • Dsa Class I Result

  • Dsa Class Ii - Mean Fluoroscence Intensity (mfi)
  • Dsa Class Ii Result

  • Dsa Final Result

Test code

4810

Specimen vol. and vacutainer information
SpecimenVacutainerVolume
Acd Whole BloodYellow Vacutainer2 ML
SerumYellow Vacutainer2 ML

Specimen stability information

Acd Whole Blood, Serum

Collection instructions

Age,Gender,Clinical history required

Specimen rejection criteria

Test run frequency

'

Turn around time

2 Working Days

Performing locations

Department

  • Hla Serology

CPT and Loinc codes

DSA (Donor Specific IgG Antibodies to Class I & II)

11500